HCM
BJDX icon

Heights Capital Management’s Bluejay Diagnostics BJDX Stock Holding History

Heights Capital Management’s Portfolio BJDX Stock Details BJDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.5K Buy
+35,400
New +$91.6K 0.01% 223

Other funds holding BJDX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
LGM
L1 Global Manager Melbourne $142M AUM
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Heights Capital Management's BJDX Position: Q2 2026 in Review

Heights Capital Management opened a new position in Bluejay Diagnostics (BJDX) in Q2 2026: 35,400 shares worth $42.5K. The stake represents 0.01% of the portfolio and ranks #223 among its holdings.

8 funds tracked by Wall St. Rank hold BJDX as of Q2 2026.

  • Heights Capital Management held 35,400 shares of Bluejay Diagnostics worth $42.5K as of Q2 2026.
  • Bluejay Diagnostics was a new Heights Capital Management position in Q2 2026.
  • Bluejay Diagnostics made up 0.01% of Heights Capital Management's portfolio in Q2 2026, its #223 holding.
  • 8 funds tracked by Wall St. Rank held Bluejay Diagnostics as of Q2 2026.

Based on Heights Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.